Ultralife Corporation (NASDAQ:ULBI - Get Free Report) CEO Michael Edward Manna bought 2,000 shares of the company's stock in a transaction dated Thursday, March 12th. The shares were purchased at an average price of $6.01 per share, with a total value of $12,020.00. Following the completion of the acquisition, the chief executive officer owned 26,874 shares of the company's stock, valued at $161,512.74. This trade represents a 8.04% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.
Ultralife Stock Up 7.0%
NASDAQ ULBI opened at $7.01 on Tuesday. Ultralife Corporation has a 1 year low of $4.07 and a 1 year high of $9.52. The stock has a market capitalization of $116.72 million, a PE ratio of -19.47 and a beta of 0.88. The company has a debt-to-equity ratio of 0.34, a current ratio of 2.99 and a quick ratio of 1.42. The business's 50-day moving average is $6.17 and its 200 day moving average is $6.28.
Ultralife (NASDAQ:ULBI - Get Free Report) last released its quarterly earnings results on Tuesday, March 10th. The technology company reported $0.12 EPS for the quarter, missing analysts' consensus estimates of $0.24 by ($0.12). Ultralife had a negative net margin of 3.09% and a positive return on equity of 3.06%. The business had revenue of $48.48 million for the quarter, compared to the consensus estimate of $57.00 million.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings restated a "sell (d+)" rating on shares of Ultralife in a report on Monday, December 29th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Ultralife currently has a consensus rating of "Sell".
Get Our Latest Analysis on Ultralife
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently made changes to their positions in ULBI. Empowered Funds LLC bought a new position in shares of Ultralife in the fourth quarter worth approximately $44,000. Lazard Asset Management LLC increased its position in shares of Ultralife by 1,650.0% during the second quarter. Lazard Asset Management LLC now owns 5,565 shares of the technology company's stock valued at $49,000 after acquiring an additional 5,247 shares in the last quarter. Prelude Capital Management LLC purchased a new position in Ultralife in the 3rd quarter worth approximately $71,000. Jane Street Group LLC purchased a new position in Ultralife in the 4th quarter worth approximately $75,000. Finally, Jones Financial Companies Lllp lifted its position in Ultralife by 1,428.7% in the 1st quarter. Jones Financial Companies Lllp now owns 15,287 shares of the technology company's stock valued at $82,000 after acquiring an additional 14,287 shares in the last quarter. Institutional investors own 30.68% of the company's stock.
About Ultralife
(
Get Free Report)
Ultralife Corporation (NASDAQ: ULBI) develops, manufactures and sells a broad range of energy and communications products for defense, medical, automotive and consumer electronics markets. The company operates through two primary segments: Power Systems and Communications Systems. In its Power Systems segment, Ultralife produces lithium-ion rechargeable cells and battery packs, primary lithium batteries, alkaline and rechargeable battery packs, chargers and battery accessories designed to meet demanding performance and safety requirements.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
